Hot Performing Stocks To Buy For 2019


Arconic (NYSE:ARNC) stock was on the rise Monday following talk about a possible buyout of the company.

Source: Shutterstock

A recent report claims that Arconic is a strong target for a buyout from several private equity firms. Among these firms that may have an interest in obtaining the producer of airplane parts is Apollo Global Management LLC.

According to these reports, Arconic is an attractive acquisition target for private equity firms due to its lacking cash generation and current valuation. This would allow these private equity firms to have easy enter and exit points in connection to buying and selling the company.

All of this talk about a private equity firm scooping up Arconic comes as it struggles to turn its business around. The company’s not been performing well lately and new CEO Chip Blankenship has been considering what to do with it. He plans to complete his review of the company this quarter, reports Bloomberg.

Hot Performing Stocks To Buy For 2019: Helix Energy Solutions Group, Inc.(HLX)


Advisors’ Opinion:

  • [By Max Byerly]

    Helix Energy Solutions Group Inc (NYSE:HLX) VP Alisa B. Johnson sold 15,244 shares of the business’s stock in a transaction on Tuesday, September 25th. The stock was sold at an average price of $9.85, for a total value of $150,153.40. Following the completion of the sale, the vice president now directly owns 285,480 shares in the company, valued at $2,811,978. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Helix Energy Solutions Group (HLX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    A number of institutional investors have recently bought and sold shares of the stock. Macquarie Group Ltd. increased its position in Helix Energy Solutions Group by 1.1% in the fourth quarter. Macquarie Group Ltd. now owns 4,442,065 shares of the oil and gas company’s stock worth $24,031,000 after buying an additional 46,900 shares in the last quarter. Municipal Employees Retirement System of Michigan purchased a new stake in Helix Energy Solutions Group in the fourth quarter worth about $263,000. Gotham Asset Management LLC purchased a new stake in Helix Energy Solutions Group in the fourth quarter worth about $1,922,000. Metropolitan Life Insurance Co. NY increased its position in Helix Energy Solutions Group by 397.2% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 47,600 shares of the oil and gas company’s stock worth $258,000 after buying an additional 38,026 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. increased its position in Helix Energy Solutions Group by 22.8% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 145,536 shares of the oil and gas company’s stock worth $787,000 after buying an additional 27,016 shares in the last quarter. Institutional investors own 94.63% of the company’s stock.


    WARNING: “Helix Energy Solutions Group (HLX) Shares Down 7.2%” was published by Ticker Report and is owned by of Ticker Report. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at www.tickerreport.com/banking-finance/4164538/helix-energy-solutions-group-hlx-shares-down-7-2.html.

    Helix Energy Solutions Group Company Profile (NYSE:HLX)

  • [By Ethan Ryder]

    Helix Energy Solutions Group (NYSE:HLX) had its price target reduced by equities researchers at Cowen from $11.00 to $10.00 in a research note issued to investors on Thursday. The brokerage currently has an “outperform” rating on the oil and gas company’s stock. Cowen’s target price indicates a potential upside of 37.93% from the stock’s current price.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Helix Energy Solutions Group (HLX)


    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Helix Energy Solutions Group Inc (NYSE:HLX) has been given an average recommendation of “Buy” by the nine analysts that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $9.20.

Hot Performing Stocks To Buy For 2019: First Citizens BancShares, Inc.(FCNCA)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Capital City Bank Group (NASDAQ: CCBG) and First Citizens BancShares (NASDAQ:FCNCA) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

  • [By Max Byerly]

    American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    First Citizens BancShares Inc. Class A (NASDAQ:FCNCA) was upgraded by equities researchers at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

Hot Performing Stocks To Buy For 2019: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)


    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) rose over 26% today after the company reported that Europe’s Committee for Medicinal Products for Human Use (CHMP) voted to recommend Zynquista in patients with type 1 diabetes. The news comes less than two months after an advisory committee to the U.S. Food and Drug Administration reached an impasse on recommending the drug in the same patient population, with eight members in favor and eight members against. 

  • [By Keith Speights, Sean Williams, and Brian Feroldi]

    But with problems come opportunities. Many companies focus on developing drugs and medical devices that help patients manage diabetes. We asked three Motley Fool healthcare contributors to identify the diabetes stocks that they would recommend investors watch closely in February. Here’s why they chose Insulet (NASDAQ:PODD), Lexicon Pharmaceuticals (NASDAQ:LXRX), and Tandem Diabetes Care (NASDAQ:TNDM).

  • [By Shane Hupp]

    Lexicon Pharmaceuticals (NASDAQ:LXRX) – Analysts at Wedbush issued their Q1 2019 earnings per share (EPS) estimates for Lexicon Pharmaceuticals in a note issued to investors on Monday, May 7th. Wedbush analyst L. Moussatos expects that the biopharmaceutical company will earn ($0.28) per share for the quarter. Wedbush currently has a “Outperform” rating and a $40.00 target price on the stock. Wedbush also issued estimates for Lexicon Pharmaceuticals’ Q2 2019 earnings at ($0.25) EPS, Q3 2019 earnings at ($0.13) EPS, Q4 2019 earnings at ($0.06) EPS, FY2020 earnings at $0.53 EPS, FY2021 earnings at $2.22 EPS and FY2022 earnings at $3.81 EPS.

  • [By Chris Lange]

    Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) is making presentations at the American Diabetes Association on June 22 to 26. Lexicon recently traded at $12.92 a share, with a consensus price target of $23.00 and a 52-week range of $7.67 to $18.00.

Leave a Reply

Your email address will not be published.